Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the effects of fulvestrant 500 mg and fulvestrant 250 mg on the proliferation marker Ki67 at 4 weeks
Critère d'inclusion
- Postmenopausal Women with Estrogen Receptor Positive Breast Cancer (T2, 3, 4b, N0-3, M0)